Thrombocytopenia differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 96: | Line 96: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Aplastic anemia | ! align="center" style="background:#DCDCDC;" + |Aplastic anemia | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |'''Acquired:''' | ||
* [[idiopathic]] | |||
* secondary to [[Radiation (medicine)|radiation]], drugs and chemicals, [[pregnancy]], [[Paroxysmal nocturnal hemoglobinuria|PNH]] and viral or [[Autoimmune disease|autoimmune]] causes | |||
'''Inherited:''' | |||
* Unknown | |||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |- | | align="center" style="background:#F5F5F5;" + | - | ||
| align="center" style="background:#F5F5F5;" + |- | | align="center" style="background:#F5F5F5;" + | - | ||
| align="center" style="background:#F5F5F5;" + |-/+ | | align="center" style="background:#F5F5F5;" + | -/+ | ||
| align="center" style="background:#F5F5F5;" + |-/+ | | align="center" style="background:#F5F5F5;" + | -/+ | ||
| align="center" style="background:#F5F5F5;" + |Biphasic (the young and the elderly) | | align="center" style="background:#F5F5F5;" + |Biphasic (the young and the elderly) | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |- | |||
| align="center" style="background:#F5F5F5;" + |- | Exposure to | ||
| align="center" style="background:#F5F5F5;" + |+ | * [[Chemical substance|Chemicals]] | ||
* [[Radiation therapy|Radiation]] | |||
History of | |||
* Prior drug use | |||
* [[Viral infections|Viral infection]] | |||
| align="center" style="background:#F5F5F5;" + | - | |||
| align="center" style="background:#F5F5F5;" + | - | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |- | | align="center" style="background:#F5F5F5;" + | - | ||
| align="center" style="background:#F5F5F5;" + |- | | align="center" style="background:#F5F5F5;" + | - | ||
| align="center" style="background:#F5F5F5;" + |[[Shortness of breath]], [[fatigue]] | | align="center" style="background:#F5F5F5;" + |[[Shortness of breath]], [[fatigue]], [[pallor]] | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* large [[Red blood cell|RBC]]<nowiki/>s | |||
* low [[Platelet|platelets]] and [[Granulocyte|granulocytes]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Hypocellular [[bone marrow]] | |||
* replacement of [[bone marrow]] by [[fat]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |NA | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |[[Bone marrow examination]] + | ||
| align="center" style="background:#F5F5F5;" + | | |||
laboratory findings | |||
| align="center" style="background:#F5F5F5;" + |Inherited forms are associated with: | |||
* [[Fanconi anemia|Fanconi Anemia]] | |||
* [[Dyskeratosis congenita]] | |||
* [[Shwachman-Diamond syndrome|Schwachman-Diamond syndrome]] | |||
* Reticular dysgenesis | |||
* Amegakaryocytic thrombocytopenia | |||
* Familial aplastic anemias | |||
* [[Preleukemia]] (monosomy 7, etc.) | |||
* Nonhematologic syndrome | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |Acute leukemia | ! align="center" style="background:#DCDCDC;" + |Acute leukemia |
Revision as of 15:58, 17 August 2018
Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombocytopenia differential diagnosis On the Web |
American Roentgen Ray Society Images of Thrombocytopenia differential diagnosis |
Risk calculators and risk factors for Thrombocytopenia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D.
Overview
Thrombocytopenia has a broad range of potential causes. While a good history and physical examination can be helpful to diagnose some of these causes such as drug-induced thrombocytopenia, they usually don't suffice and further evaluation is often needed. There are also some useful points that may guide the physician to an appropriate diagnosis. For example, asymptomatic, isolated thrombocytopenia most probably suggests ITP, while thrombocytopenia in critically ill, hospitalized patients is usually suggestive of iatrogenic causes (eg. dilution), platelet consumption, bone marrow suppression from infection/sepsis, or even drug-induced thrombocytopenia. One should consider however, that a wide variety of other conditions such as autoimmune disorders, nutrient deficiencies, thrombotic microangiopathies could all as well cause thrombocytopenia.
Thrombocytopenia Differential Diagnosis
Differentiating the diseases that can cause thrombocytopenia:
Category | Condition | Etiology | Mechanism | Inherited | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | |||||||||||||||||||||||||
Lab Findings | Imaging | |||||||||||||||||||||||||||
Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | ||||||||||||||||
Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Plt | HB | WBC | |||||||||||||||||||||||
Hematology | Bone marrow disorders | Myelodysplastic syndromes[1] |
|
+ | - | - | -/+ | + | Elderly | Exposure to | + | Petechiae, purpura, diffuse erythematous rash | + | Nl | + | + | Shortness of breath, fatigue | ↓ | ↓ | ↓ |
|
|
Nl | Nl | Nl | NA | Bone marrow examination + clinical manifestation |
|
Aplastic anemia | Acquired:
Inherited:
|
+ | - | - | -/+ | -/+ | Biphasic (the young and the elderly) |
Exposure to History of
|
- | - | + | Nl | - | - | Shortness of breath, fatigue, pallor | ↓ | ↓ | ↓ |
|
|
NA | Bone marrow examination +
laboratory findings |
Inherited forms are associated with:
| |||||
Acute leukemia | + | |||||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | + | |||||||||||||||||||||||||||
Thrombotic microangiopathy (TMA) | Thrombotic thrombocytopenic purpura (TTP) | Deficiency of, or antibodies to, the metalloprotease ADAMTS13 | + | -/+ | + | Any age | + | ↓ | Fragmented RBCs | Nl | Nl |
| ||||||||||||||||
Hemolytic uremic syndrome (HUS) |
|
+ | -/+ | + | Children | Nl | Nl |
| ||||||||||||||||||||
DIC | + | - | + | ↑↑ | ↑ | |||||||||||||||||||||||
Congenital platelet disorders | MYH-9 related disorders | + | - | Large platelets | ||||||||||||||||||||||||
Bernard-Soulier syndrome | Absence of
Gp Ib-IX-V |
+ | - | |||||||||||||||||||||||||
Gray platelet syndrome | + | - | ||||||||||||||||||||||||||
Wiskott-Aldrich syndrome | Mutation in GATA-1 | + | - | |||||||||||||||||||||||||
Thrombocytopenia with absent radius (TAR) syndrome | + | - | ||||||||||||||||||||||||||
Alport syndrome | + | - | ||||||||||||||||||||||||||
Von Willebrand disease | + | |||||||||||||||||||||||||||
Nutrient deficiencies | Folate, vitamin B12, copper | + | ||||||||||||||||||||||||||
Category | Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Rheumatologic/autoimmune disorders | ITP |
|
+ | + | - | - | + | Any age | - | - | Ecchymoses and | + Mucocutaneous | Nl | - | - | - | ↓↓↓ | Nl | Nl | Nl | Large platelets, otherwise normal | Nl | Nl | Nl | NA | Diagnosis of exclusion | Spontaneous remission | |
Systemic lupus erythematosus (SLE) | + | |||||||||||||||||||||||||||
Antiphospholipid syndrome (APS) | Autoantibody-mediated syndrome | + | ||||||||||||||||||||||||||
Felty's syndrome | Splenomegaly | + | ||||||||||||||||||||||||||
Infection-induced | Bacterial infections | Sepsis | Direct bone marrow suppression | + | + | ↑ | ↑ | |||||||||||||||||||||
Helicobacter pylori | Immune thrombocytopenia | + | ||||||||||||||||||||||||||
Tick-borne infection | + | |||||||||||||||||||||||||||
Viral infections | HIV | An ITP-like condition called primary HIV-associated thrombocytopenia | + | + | + | |||||||||||||||||||||||
Other viruses such as rubella, mumps, varicella, parvovirus, hepatitis C, & Epstein-Barr virus | + | |||||||||||||||||||||||||||
Parasitic infections | Malaria | |||||||||||||||||||||||||||
Babesiosis | ||||||||||||||||||||||||||||
Category | Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Medication/toxicity | Antibiotics/ | Occurrence of drug-dependent, platelet-reactive antibodies | + | + | ||||||||||||||||||||||||
Heparin-induced thrombocytopenia | Anti-heparin/PF4 antibody | + | ELISA | Early or delayed-onset | ||||||||||||||||||||||||
Cytotoxic chemotherapy | + | |||||||||||||||||||||||||||
Radiation therapy | Predictable, dose-dependent myelosuppression | + | ||||||||||||||||||||||||||
OTC agents | Quinine-containing beverages | |||||||||||||||||||||||||||
GI | Chronic liver disease | + | ↓ | + | + | ↓↓ | ↓ | |||||||||||||||||||||
Portal hypertension | ||||||||||||||||||||||||||||
Category | Condition | Etiology | Decreased platelet production | Platelet destruction in blood | Platelet destruction in spleen | Inherited | Acquried | Demography | History | Fever | Rash | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings | |
Vascular | Giant capillary hemangioma | Platelet destruction | + | |||||||||||||||||||||||||
Aortic aneurysm | Platelet destruction | + | ||||||||||||||||||||||||||
Cardiopulmonary bypass | Platelet destruction | + | ||||||||||||||||||||||||||
Other | Alcohol | + | - | + | - | + | History of alcohol use | - | - | - | Nl | + | + | ↓ | ↓ | ↓ | Cytopenia | Cytopenia | Clinical manifestation | |||||||||
Post-transfusion purpura[2][3] | Platelet destruction by anti-platelet antibodies | - | + | - | - | + | Women |
|
- | Purpura, petechiae | + | ↓ | - | - | - | ↓↓↓ | ↓ | Nl | Nl | NA | Nl | Nl | Nl | NA | Positive circulating alloantibody to a common platelet antigen |
| ||
Gestational thrombocytopenia[4] | Might be physiologic adaptation of pregnancy | - | - | - | - | + | Pregnant women |
|
- | - | - | Nl | - | - | - | ↓ | Nl | Nl | Nl | NA | Nl | Nl | Nl | NA | Diagnosis of exclusion |
| ||
HELLP syndrome[5][6] | Unknown | - | + | - | - | + | Pregnant > 25 years |
|
- | - | + | ↑ | - | + | ↓ | ↓ | Nl | NA | Nl | Nl | Proteinuria | NA | Lab abnormalities |
|
References
- ↑ Natelson, Ethan A.; Pyatt, David (2013). "Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog". Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.
- ↑ McCrae, Keith R.; Herman, Jay H. (1996). "Posttransfusion purpura: Two unusual cases and a literature review". American Journal of Hematology. 52 (3): 205–211. doi:10.1002/(SICI)1096-8652(199607)52:3<205::AID-AJH13>3.0.CO;2-E. ISSN 0361-8609.
- ↑ Pavenski, Katerina; Webert, Kathryn E.; Goldman, Mindy (2008). "Consequences of transfusion of platelet antibody: a case report and literature review". Transfusion. 48 (9): 1981–1989. doi:10.1111/j.1537-2995.2008.01796.x. ISSN 0041-1132.
- ↑ Reese, Jessica A.; Peck, Jennifer D.; Deschamps, David R.; McIntosh, Jennifer J.; Knudtson, Eric J.; Terrell, Deirdra R.; Vesely, Sara K.; George, James N. (2018). "Platelet Counts during Pregnancy". New England Journal of Medicine. 379 (1): 32–43. doi:10.1056/NEJMoa1802897. ISSN 0028-4793.
- ↑ Barnhart, Lynette (2015). "HELLP Syndrome and the Effects on the Neonate". Neonatal Network. 34 (5): 269–273. doi:10.1891/0730-0832.34.5.269. ISSN 0730-0832.
- ↑ Haram, Kjell; Svendsen, Einar; Abildgaard, Ulrich (2009). "The HELLP syndrome: Clinical issues and management. A Review". BMC Pregnancy and Childbirth. 9 (1). doi:10.1186/1471-2393-9-8. ISSN 1471-2393.